The Health Sciences Authority (HSA) in Singapore recently proposed a regulatory framework for Complementary Health Products, which include health supplements, traditional medicines, and other related products. Key points include:
-
Mandatory Notification: Health supplements will require mandatory product listing to ensure compliance with safety, quality, labeling, and advertising regulations. Previously, health supplements were subject to voluntary notification.
-
Product Traceability: The new framework aims to improve market visibility for traceability, enabling quick access to information during product recalls.
-
Advertising Regulations: Advertisements for Consumer Health Products will no longer need pre-publication permits but must comply with new restrictions, focusing on preventing misleading claims and ensuring safety.
-
Implementation Timeline: The framework will be rolled out in phases, with full implementation expected by the third quarter of 2030, including a two-year grace period for compliance.
-
Regulatory Shift: The proposal also reflects a broader regulatory shift from the Medicines Act to the Health Products Act, offering more flexibility and stronger enforcement measures.
The public consultation on these proposed regulations began on July 1 and is set to conclude on July 29.
